Sekisui Aptitude Metrix Covid-19 Test
Brand: Sekisui Diagnostics, LLC
USD 756.0 — In stock
How to order
In stock — USD 756.0.
Prefer to order with a person? +1 855 932 4721 · info@priconmed.com · Contact us.
Variants
- COVID-19 Test, 25 tests/kt — USD 756.0 — In stock — SKU MTRX-C19-25PK
Product intelligence — AI-assisted — defer to the manufacturer's IFU
01 — At a glance
Product overview
The Sekisui Aptitude Metrix COVID-19 Test is a molecular diagnostic tool designed for the qualitative detection of SARS-CoV-2 nucleic acids. This CLIA-waived platform supports both anterior nasal swab and saliva specimens, providing a more versatile diagnostic option than standard antigen-only rapid tests for point-of-care and home settings.
- Brand
- Sekisui Diagnostics, LLC
- Category
- Covid-19 Lab – Point of Care
- Packaging
- 25 tests per kit
- Sterility
- Sterile
- Common Use
- SARS-CoV-2 nucleic acid detection
How to think about this product
Buyers should distinguish the Metrix system from standard lateral flow antigen tests as it utilizes molecular nucleic acid detection, which typically offers different performance characteristics in clinical settings. Unlike many rapid tests that only support nasal swabbing, this platform allows for saliva collection, providing flexibility for patient comfort. The product is positioned for point-of-care and home use under CLIA-waived status, and this specific SKU is a multi-test kit containing 25 tests and a reusable reader unit.
Sources
02 — Clinical applications
Where this product is used
Sekisui Aptitude Metrix Covid-19 Test is commonly used in:
- CLIA-waived point-of-care SARS-CoV-2 molecular testing
- Non-prescription home use diagnostic testing
- Anterior nasal swab specimen collection and analysis
- Saliva-based COVID-19 molecular screening
- Rapid diagnostic interpretation via Metrix reader device
03 — People also ask
Frequently asked questions
Q01 What technology does the Metrix COVID-19 Test use for detection?
This is a molecular in vitro diagnostic test designed to detect SARS-CoV-2 nucleic acid, rather than viral antigens.
Q02 What specimen types are authorized for use with this test?
The test is authorized for use with both anterior nasal swab specimens and saliva specimens.
Q03 Is this product FDA cleared or approved?
This product is not FDA cleared or approved; it is currently authorized by the FDA under an Emergency Use Authorization (EUA).
Q04 What are the contents of the MTRX-C19-25PK kit?
The kit includes 25 individual COVID-19 tests and a reader device required for the interpretation of test results.
Q05 Is the Metrix COVID-19 Test kit provided in a sterile state?
According to distributor specifications from Fisher Scientific, this test kit is categorized as sterile.
04 — Wholesale · For verified medical professionals
Need a bulk quote?
Ordering 5+ cases or stocking a facility? Our wholesale team can offer custom pricing, standing orders, and net-30 terms.
- Net-30 terms
- Custom pricing
- 1 business day response